Prospective observational studies of the management and outcomes in patients with atrial fibrillation: A systematic review

Journal of the Saudi Heart Association - Tập 24 - Trang 243-252 - 2012
Ahmad S. Hersi1, Alawi A. Alsheikh-Ali2,3, Mohammad Zubaid4, Jassim Al Suwaidi5
1Department of Cardiac Sciences, King Saud University, Riyadh
2Heart and Vascular Institute, Sheikh Khalifa Medical City, Abu Dhabi
3Tufts Clinical and Translational Science Institute and Department of Medicine, Tufts University School of Medicine, Boston, MA
4Department of Medicine, Faculty of Medicine, Kuwait University
5Hamad Medical Corporation, Doha

Tài liệu tham khảo

Stewart, 2001, Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study, Heart, 86, 516, 10.1136/heart.86.5.516 Go, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, JAMA: the Journal of the American Medical Association, 285, 2370, 10.1001/jama.285.18.2370 Lloyd-Jones, 2004, Lifetime risk for development of atrial fibrillation: the Framingham Heart Study, Circulation, 110, 1042, 10.1161/01.CIR.0000140263.20897.42 Camm, 2007, Rate control in the medical management of atrial fibrillation, Heart, 93, 35, 10.1136/hrt.2006.099903 Coyne, 2006, Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States, Value Health, 9, 348, 10.1111/j.1524-4733.2006.00124.x Psaty, 1997, Incidence of and risk factors for atrial fibrillation in older adults, Circulation, 96, 2455, 10.1161/01.CIR.96.7.2455 Ryder, 1999, Epidemiology and significance of atrial fibrillation, American Journal of Cardiology, 84, 131R, 10.1016/S0002-9149(99)00713-4 Wyse, 2002, A comparison of rate control and rhythm control in patients with atrial fibrillation, The New England Journal of Medicine, 347, 1825, 10.1056/NEJMoa021328 De Denus, 2005, Rate vs. rhythm control in patients with atrial fibrillation: a meta-analysis, Archives of Internal Medicine, 165, 258, 10.1001/archinte.165.3.258 Van Gelder, 2006, Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies, Europace, 8, 935, 10.1093/europace/eul106 Braunwald, 1997, Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities, The New England Journal of Medicine (NEJM), 337, 1360, 10.1056/NEJM199711063371906 Committee on Comparative Effectiveness Research Prioritization Institute of Medicine, 2009 Moher, 2010, The PRISMA group: preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, International Journal of Surgery, 8, 336, 10.1016/j.ijsu.2010.02.007 Kerr, 1998, The Canadian registry of atrial fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation, The American Journal of Cardiology, 82, 82N, 10.1016/S0002-9149(98)00589-X Friberg, 2007, Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF), European Heart Journal, 28, 2346, 10.1093/eurheartj/ehm308 Pappone, 2008, Atrial fibrillation progression and management: a 5-year prospective follow-up study, Heart Rhythm, 5, 1501, 10.1016/j.hrthm.2008.08.011 Nieuwlaat, 2005, Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation, European Heart Journal, 26, 2422, 10.1093/eurheartj/ehi505 Ntep-Gweth, 2010, Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon, Europace, 12, 482, 10.1093/europace/euq006 Camm, 2011, Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation), Journal of the American College of Cardiology, 58, 493, 10.1016/j.jacc.2011.03.034 Potpara, 2011, Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study, Chest, 140, 902, 10.1378/chest.10-2963 Kowey, 2010, Practice patterns among United States cardiologists for managing adults with atrial fibrillation (AFFECTS), The American Journal of Cardiology, 105, 1122, 10.1016/j.amjcard.2009.11.046 Vandenbroucke, 2008, Observational research, randomised trials, and two views of medical science, PLoS Medicine, 5, e67, 10.1371/journal.pmed.0050067 Registries for Evaluating Patient Outcomes: A User’s Guide. Agency for Healthcare Research and Quality (AHRQ). 2010; second ed., Publication No. 10-EHC049. Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA: the Journal of the American Medical Association, 285, 2864, 10.1001/jama.285.22.2864 Camm, 2010, Europace, 12, 1360, 10.1093/europace/euq350 Chandrashekhar, 2009, Mitral stenosis, Lancet, 374, 1271, 10.1016/S0140-6736(09)60994-6 Carapetis, 2005, The global burden of group A streptococcal diseases, The Lancet Infectious Diseases, 5, 685, 10.1016/S1473-3099(05)70267-X Zubaid, 2011, Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) investigators, Circulation: Cardiovascular Quality and Outcomes, 4, 477 Global Registry of Acute Coronary Events (GRACE) 2012. Scientific Advisory Committee. [Cited 2012 Mar 6]. Available from: <http://www.outcomes-umassmed.org/grace/>. Granger, 2011, Apixaban versus Warfarin in Patients with Atrial Fibrillation (ARISTOTLE), The New England Journal of Medicine, 365, 981, 10.1056/NEJMoa1107039 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation (RE-LY), The New England Journal of Medicine, 361, 1139, 10.1056/NEJMoa0905561 Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF), The New England Journal of Medicine, 365, 883, 10.1056/NEJMoa1009638 Connolly, 2011, Apixaban in patients with atrial fibrillation (AVERROES), The New England Journal of Medicine, 364, 806, 10.1056/NEJMoa1007432 Kakkar, 2012, International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD), American Heart Journal, 163, 13, 10.1016/j.ahj.2011.09.011 Zubaid, 2011, Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation in the Arab Middle East, Circulation: Cardiovascular Quality and Outcomes, 4, 477 Nabauer, 2009, The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management, Europace, 11, 423, 10.1093/europace/eun369 Piccini, 2011, Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF, American Heart Journal, 162, 606, 10.1016/j.ahj.2011.07.001 Parekh-Bhurke, 2011, Uptake of methods to deal with publication bias in systematic reviews has increased over time, but there is still much scope for improvement, Journal of Clinical Epidemiology, 64, 349, 10.1016/j.jclinepi.2010.04.022